ZJKBGLKCNNVECZ-UHFFFAOYSA-N
C27H22ClN9O3 — CID 86596025
Data last refreshed: (MolForge compound catalog, from PubChem)
About ZJKBGLKCNNVECZ-UHFFFAOYSA-N
ZJKBGLKCNNVECZ-UHFFFAOYSA-N (PubChem CID 86596025) has the molecular formula C27H22ClN9O3 and a molecular weight of 555.99 g/mol. Its IUPAC name is N-(diaminomethylidene)-1-pyridin-2-ylpyrrolo[2,3-b]pyridine-3-carboxamide;1-pyridin-2-ylpyrrolo[2,3-b]pyridine-3-carboxylic acid;hydrochloride.
Molecular Properties
| Compound Name | ZJKBGLKCNNVECZ-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 86596025 |
| Molecular Formula | C27H22ClN9O3 |
| Molecular Weight | 555.99 g/mol |
| Exact Mass | 555.15 |
| IUPAC Name | N-(diaminomethylidene)-1-pyridin-2-ylpyrrolo[2,3-b]pyridine-3-carboxamide;1-pyridin-2-ylpyrrolo[2,3-b]pyridine-3-carboxylic acid;hydrochloride |
| SMILES | Cl.NC(N)=NC(=O)c1cn(-c2ccccn2)c2ncccc12.O=C(O)c1cn(-c2ccccn2)c2ncccc12 |
| InChI | InChI=1S/C14H12N6O.C13H9N3O2.ClH/c15-14(16)19-13(21)10-8-20(11-5-1-2-6-17-11)12-9(10)4-3-7-18-12;17-13(18)10-8-16(11-5-1-2-6-14-11)12-9(10)4-3-7-15-12;/h1-8H,(H4,15,16,19,21);1-8H,(H,17,18);1H |
| InChIKey | ZJKBGLKCNNVECZ-UHFFFAOYSA-N |
| XLogP | 3.37 |
| TPSA | 180.19 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 555.99 |
| LogP ≤ 5 | 3.37 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 86596025 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.